GoodRx (NASDAQ: GDRX) CAO Romin Nabiey to depart in 2026

Rhea-AI Filing Summary

GoodRx Holdings, Inc. announced that Chief Accounting Officer Romin Nabiey has submitted his resignation, effective April 3, 2026, to pursue other opportunities. He will remain with the company through June 8, 2026 to help transition his responsibilities. The company stated that his resignation is not due to any disagreement regarding its operations, policies, or practices, and expressed appreciation for his years of service.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

0001809519FALSE2701 Olympic BoulevardSanta MonicaCalifornia00018095192026-03-242026-03-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________________________

FORM 8-K

________________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 24, 2026

________________________________________

GoodRx Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

________________________________________

Delaware	001-39549	47-5104396
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
2701 Olympic Boulevard
Santa Monica, California		90404
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (855) 268-2822

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the

registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share		GDRX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act

of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition

period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Compensatory Arrangements of Certain Officers.

Chief Accounting Officer Resignation

On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, Inc. (the

“Company”), effective April 3, 2026 in order to pursue other opportunities. Mr. Nabiey will remain an employee of the

Company through June 8, 2026 to support the transition of his responsibilities. Mr. Nabiey’s resignation was not a result of

any disagreement between the Company and Mr. Nabiey on any matter related to the operations, policies, or practices of

the Company. The Company thanks Mr. Nabiey for his years of contribution and service to the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report

to be signed on its behalf by the undersigned hereunto duly authorized.

			GOODRX HOLDINGS, INC.
Date:	March 27, 2026	By:	/s/ Christopher McGinnis
			Name: Christopher McGinnis Title: Chief Financial Officer & Treasurer

FAQ

What executive change did GoodRx (GDRX) disclose in this 8-K?

GoodRx disclosed that Chief Accounting Officer Romin Nabiey has resigned. His resignation is effective April 3, 2026, with continued employment through June 8, 2026, to support the transition of his responsibilities within the company.

When is GoodRx CAO Romin Nabiey’s resignation effective?

Romin Nabiey’s resignation as Chief Accounting Officer is effective April 3, 2026. He will remain an employee until June 8, 2026, to assist with transitioning his accounting and financial reporting responsibilities at GoodRx Holdings, Inc.

Did GoodRx report any disagreement related to the CAO’s resignation?

GoodRx stated that Romin Nabiey’s resignation was not the result of any disagreement with the company. This includes no disputes over its operations, policies, or practices, indicating the departure is not tied to reported internal conflicts.

How long will GoodRx’s departing CAO stay to support the transition?

Although his resignation is effective April 3, 2026, Romin Nabiey will remain employed at GoodRx through June 8, 2026. During this period, he will support the orderly transition of his Chief Accounting Officer responsibilities.

What reason did GoodRx give for Romin Nabiey’s departure as CAO?

GoodRx reported that Romin Nabiey resigned as Chief Accounting Officer to pursue other opportunities. The company did not provide additional detail, but it explicitly noted that his resignation was not due to any disagreement with the organization.

Who signed GoodRx’s 8-K reporting the CAO resignation?

The 8-K reporting the resignation was signed on behalf of GoodRx Holdings, Inc. by Christopher McGinnis. He is identified in the filing as the company’s Chief Financial Officer and Treasurer, acting as the authorized signatory.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.3 KB